Dicky Levenus Tahapary
Overview
Explore the profile of Dicky Levenus Tahapary including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
175
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Anggraini C, Nusanti S, Tahapary D, Khoe L
Acta Med Indones
. 2025 Jan;
56(4):461-468.
PMID: 39865049
Background: Graves' ophthalmopathy (GO) ocular abnormalities can persist even after treatment, negatively impacting patients' psychological and social health. The Indonesian Graves' Ophthalmopathy Quality of Life (GO-QoL) Questionnaire has not been...
2.
Wafa S, Tahapary D, Yunihastuti E, Wibowo H, Rumende C, Harimurti K, et al.
Acta Med Indones
. 2025 Jan;
56(4):483-492.
PMID: 39865044
Background: Central obesity increases the risk of developing poor outcomes of COVID-19. The pro-inflammatory state and antibody dysfunction are thought to contribute to poor outcomes; however, the evidence is unclear....
3.
Kurniawan J, Djianzonie J, Mulyana E, Tahapary D, Sulaiman A, Wijaya I, et al.
Acta Med Indones
. 2024 Oct;
56(3):282-290.
PMID: 39463115
Background: Hepatocellular carcinoma (HCC) is a cancer with poor prognosis. Indonesia is a country with high prevalence of chronic hepatitis B infection. The performance of alpha fetoprotein (AFP) as a...
4.
Wisnu W, Alwi I, Nafrialdi N, Pemayun T, Pantoro N, Wijaya C, et al.
J Lipid Atheroscler
. 2024 Oct;
13(3):358-370.
PMID: 39355401
Objective: Graves' disease (GD) is characterized by thyroid overactivity. Anti-thyroid drugs (ATDs), such as propylthiouracil (PTU) and methimazole (MMI), are commonly used for GD treatment, and studies have suggested a...
5.
Barus N, Tahapary D, Kurniawan F, Sinto R, Wafa S, Wisnu W, et al.
Infect Dis Rep
. 2024 Sep;
16(5):894-905.
PMID: 39311212
(1) Background: This study aims to assess visceral fat values, waist circumference (WC), body mass index (BMI), and body fat percentage for their ability to predict poor outcomes during COVID-19...
6.
Kalista K, Rahma H, Tahapary D, Nababan S, Jasirwan C, Kurniawan J, et al.
Endocrinol Diabetes Metab Case Rep
. 2024 Jul;
2024(3).
PMID: 38953327
Summary: Hypoglycemia is one of the paraneoplastic syndrome manifestations that arise from primary and secondary liver cancer. Hypoglycemia usually presents in the late stage of the disease and indicates a...
7.
Laksmi P, Purnamasari D, Sofian N, Sari N, Kurniawan M, Sukrisman L, et al.
Heliyon
. 2024 Jan;
10(2):e24018.
PMID: 38293379
Aims: To investigate the correlation between glycaemic control with component of Physio-Cognitive Decline Syndrome (PCDS) and among each component of PCDS itself. Methods: A cross sectional study was conducted (January...
8.
Kurniawan F, Subekti I, Yunir E, Harbuwono D, Purnamasari D, Tarigan T, et al.
Curr Res Transl Med
. 2024 Jan;
72(2):103437.
PMID: 38244275
Background: Type 2 diabetes (T2D) is a progressive disease. Many drugs currently being used for the management of T2D have minimal effect on pancreatic beta cells regeneration. Cell-based therapies might...
9.
Purnamasari D, Simanjuntak C, Tricaesario C, Tahapary D, Harbuwono D, Yunir E
Heliyon
. 2023 Aug;
9(8):e18887.
PMID: 37593625
Background: Leptin, adiponectin and its ratio (L/A), as well as adipocyte fatty acid binding protein (A-FABP) have shown association to type 2 diabetes and atherosclerosis. Since first degree relatives (FDR)...
10.
Sugiyanto M, Gosal S, Kosim A, Tahapary D, Sianipar I
Eur J Haematol
. 2023 Mar;
111(1):4-14.
PMID: 36950969
Hematopoietic stem cell (HSC) transplantation's success lies in its ability to induce immune reconstitution. To date, there is no review published to compare the immune reconstitution among the three sources...